Cardinal Health (CAH) Tops Q1 EPS by 9c, Reaffirms FY18 EPS Guidance

Go back to Cardinal Health (CAH) Tops Q1 EPS by 9c, Reaffirms FY18 EPS Guidance

Cardinal Health (CAH) PT Lowered to $67 at Jefferies; Remains Sidelined

November 7, 2017 8:10 AM EST

Jefferies lowered its price target on Cardinal Health (NYSE: CAH) to $67.00 (from $77.00) while maintaining a Hold rating following the company's earnings release. Despite missing consensus revenue by ~2.5% ($32.6B vs. $33.4B), CAH beat on earnings for the quarter as a result of better than expected... More

Cardinal Health (CAH) Announces CFO Mike Kaufmann as Next CEO and Board Member; Effective Jan. 1, 2018

November 6, 2017 6:59 AM EST

Cardinal Health (NYSE: CAH) announced today that it has named Mike Kaufmann, 54, its current chief financial officer, to serve as the company's next chief executive officer and join the board of directors, effective Jan. 1, 2018. Kaufmann will succeed George Barrett, 62, Cardinal Health's chairman and chief executive officer since 2009, who will continue to serve as executive chairman of the board of directors through the annual meeting of shareholders in November 2018. At that time, Gregory Kenny, Cardinal Health's lead independent director, will assume the role of non-executive chairman.

Kaufmann is a 27-year veteran of Cardinal... More